Serum chemokine levels and developmental outcome in preterm infants

Early Human Development

Volumn 87, Issue 6, 2011, Pages 439-443

  Kinjo, Tadamune ^a,b   Ohga, Shouichi ^a,b   Ochiai, Masayuki ^a,b   Honjo, Satoshi ^a,c   Tanaka, Tamami ^a   Takahata, Yasushi ^a   Ihara, Kenji ^a,b   Hara, Toshiro ^a,b  

^a KYUSHU UNIVERSITY   (Japan)

^b KYUSHU UNIVERSITY HOSPITAL   (Japan)

^c FUKUOKA NATIONAL HOSPITAL   (Japan)

Author keywords

CCL2; Chemokine; CXCL8; Outcome; Very low birth weight infant

Indexed keywords

CXCL9 CHEMOKINE; GAMMA INTERFERON INDUCIBLE PROTEIN 10; INTERLEUKIN 8; MONOCYTE CHEMOTACTIC PROTEIN 1; STEROID;

APGAR SCORE; ARTICLE; ARTIFICIAL VENTILATION; BIRTH WEIGHT; CESAREAN SECTION; CHILD DEVELOPMENT; CHORIOAMNIONITIS; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CONCENTRATION (PARAMETERS); CORRELATION ANALYSIS; CORRELATION COEFFICIENT; FEMALE; GESTATIONAL AGE; HUMAN; MALE; MENTAL DEVELOPMENT; MULTIVARIATE ANALYSIS; NEWBORN; NEWBORN ASSESSMENT; OUTCOME ASSESSMENT; OXYGEN THERAPY; PATENT DUCTUS ARTERIOSUS; PREMATURITY; PRENATAL CARE; PROSPECTIVE STUDY; RESPIRATORY DISTRESS SYNDROME; SEPSIS; STEROID THERAPY; VERY LOW BIRTH WEIGHT;

APGAR SCORE; CHEMOKINES; CHILD DEVELOPMENT; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; INFANT, VERY LOW BIRTH WEIGHT; MALE; MULTIVARIATE ANALYSIS; PROSPECTIVE STUDIES;

EID: 79955745047     PISSN: 03783782     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.earlhumdev.2011.03.006     Document Type: Article

References (36)

1. Gotsch F., Romero R., Kusanovic J.P., Mazaki-Tovi S., Pineles B.L., Erez O., et al. The fetal inflammatory response syndrome. Clin Obstet Gynecol 2007, 50:652-683.
2. Bashiri A., Burstein E., Mazor M. Cerebral palsy and fetal inflammatory response syndrome: a review. J Perinat Med 2006, 34:5-12.
3. Huang H.C., Wang C.L., Huang L.T., Chuang H., Liu C.A., Hsu T.Y., et al. Association of cord blood cytokines with prematurity and cerebral palsy. Early Hum Dev 2004, 77:29-36.
4. Hansen-Pupp I., Hallin A.L., Hellström-Westas L., Cilio C., Berg A.C., Stjernqvist K., et al. Inflammation at birth is associated with subnormal development in very preterm infants. Pediatr Res 2008, 64:183-188.
5. Paananen R., Husa A.K., Vuolteenaho R., Herva R., Kaukola T., Hallman M. Blood cytokines during the perinatal period in very preterm infants: relationship of inflammatory response and bronchopulmonary dysplasia. J Pediatr 2009, 154:39-43.
6. Laborada G., Nesin M. Interleukin-6 and Interleukin-8 are elevated in the cerebrospinal fluid of infants exposed to chorioamnionitis. Biol Neonate 2005, 88:136-144.
7. Sherwin C., Fern R. Acute lipopolysaccharide-mediated injury in neonatal white matter glia: role of TNF-α, IL-1β, and calcium. J Immunol 2005, 175:155-161.
8. Gerard C., Rollins B.J. Chemokines and disease. Nat Immunol 2001, 2(2):108-115.
9. Savarin-Vuaillat C., Ransohoff R.M. Chemokines and chemokine receptors in neurological disease: raise, retain, or reduce?. Neurotherapeutics 2007, 4:590-601.
10. Schmitz T., Chew L.J. Cytokines and myelination in the central nervous system. Sci World J 2008, 8:1119-1147.
11. Parsadaniantz S.M., Rostène W. Chemokines and neuromodulation. J Neuroimmunol 2008, 198:62-68.
12. Briana D.D., Boutsikou M., Baka S., Papadopoulos G., Gourgiotis D., Puchner K.P., et al. Perinatal plasma monocyte chemotactic protein-1 concentrations in intrauterine growth restriction. Mediat Inflamm 2007, 2007:65032.
13. Shalak L.F., Laptook A.R., Jafri H.S., Ramilo O., Perlman J.M. Clinical chorioamnionitis, elevated cytokines, and brain injury in term infants. Pediatrics 2002, 110:673-680.
14. Nakai K., Suzuki K., Oka T., Murata K., Sakamoto M., Okamura K., et al. The Tohoku study of child development: A cohort study of effects of perinatal exposures to methylmercury and environmentally persistent organic pollutants on neurobehavioral development in Japanese children. Tohoku J Exp Med 2004, 202:227-237.
15. Kono Y., Mishina J., Sato N., Watanabe T., Honma Y. Developmental characteristics of very low-birthweight infants at 18months' corrected age according to birthweight. Pediatr Int 2008, 50:23-28.
16. Angelone D.F., Wessels M.R., Coughlin M., Suter E.E., Valentini P., Kalish L.A., et al. Innate immunity of the human newborn is polarized toward a high ratio of IL-6/TNF-alpha production in vitro and in vivo. Pediatr Res 2006, 60:205-209.
17. Huang H.C., Tai F.Y., Wang F.S., Liu C.A., Hsu T.Y., Ou C.Y., et al. Correlation of augmented IL-8 production to premature chronic lung disease: implication of posttranscriptional regulation. Pediatr Res 2005, 58:216-221.
18. Takahashi N., Uehara R., Kobayashi M., Yada Y., Koike Y., Kawamata R., et al. Cytokine profiles of seventeen cytokines, growth factors and chemokines in cord blood and its relation to perinatal clinical findings. Cytokine 2010, 49:331-337.
19. Dimitrijevic O.B., Stamatovic S.M., Keep R.F., Andjelkovic A.V. Absence of the chemokine receptor CCR2 protects against cerebral ischemia/reperfusion injury in mice. Stroke 2007, 38:1345-1353.
20. Che X., Ye W., Panga L., Wu D.C., Yang G.Y. Monocyte chemoattractant protein-1 expressed in neurons and astrocytes during focal ischemia in mice. Brain Res 2001, 902:171-177.
21. Chen Y., Hallenbeck J.M., Ruetzler C., Bol D., Thomas K., Berman N.E.J., et al. Overexpression of monocyte chemoattractant potein 1 in the brain exacerbates ischemic brain injury and is associated with recruitment of inflammatory cells. J Cereb Blood Flow Metab 2003, 23:748-755.
22. Hughes P.M., Allegrini P.R., Rudin M., Perry H., Mir A.K., Wiessner C. Monocyte chemoattractant protein-1 deficiency is protective in a murine stroke model. J Cereb Blood Flow Metab 2002, 22:308-317.
23. Yan Y.P., Sailor K.A., Lang B.T., Park S.W., Vemuganti R., Dempsey R.J. Monocyte chemoattractant protein-1 plays a critical role in neuroblast migration after focal cerebral ischemia. J Cereb Blood Flow Metab 2007, 27:1213-1224.
24. Xu Q., Wang S., Jiang X., Zhao Y., Gao M., Zhang Y., et al. Hypoxia-induced astrocytes promote the migration of neural progenitor cells via vascular endothelial factor, stem cell factor, stromal-derived factor-1α and monocyte chemoattractant protein-1 upregulation in vitro. Clin Exp Pharmacol Physiol 2007, 34:624-631.
25. Liu X.S., Zhang Z.G., Zhang R.L., Gregg S.R., Wang L., Yier T., et al. Chemokine ligand 2 (CCL2) induces migration and differentiation of subventricular zone cells after stoke. J Neurosci Res 2007, 85:2120-2125.
26. Belmadani A., Tran P.B., Ren D., Miller R.J. Chemokines regulate the migration of neural progenitors to sites of neuroinflammation. J Neurosci 2006, 26:3182-3191.
27. Lawrence D.M., Seth P., Durham L., Diaz F., Boursiquot R., Ransohoff R.M., et al. Astrocyte differentiation selectively upregulates CCL2/monocyte chemoattractant protein-1 in cultured human brain-derived progenitor cells. Glia 2006, 53:81-91.
28. Chintawar S., Cayrol R., Antel J., Pandolfo M., Prat A. Blood-brain-barrier promotes differentiation of human fetal neural precursor cells. Stem Cells 2009, 27:838-846.
29. Madrigal J.L., Leza J.C., Polak P., Kalinin S., Feinstein D.L. Astrocyte-derived MCP-1 mediates neuroprotective effects of noradrenaline. J Neurosci 2009, 29:263-267.
30. Coughlan C.M., McManus C.M., Sharron M., Gao Z.Y., Murphy D., Jaffer S., et al. Expression of multiple functional chemokine receptors and monocyte chemoattractant protein-1 in human neurons. Neuroscience 2000, 97:591-600.
31. Banisadr G., Gosselin R.D., Mechighel P., Kitabgi P., Rostène W., Parsadaniantz S.M. Highly regionalized neuronal expression of monocyte chemoattractant protein-1 (MCP-1/CCL2) in rat brain: evidence for its colocalization with neurotransmitters and neuropeptides. J Comp Neurol 2005, 489:275-292.
32. Meng S.Z., Oka A., Takashima S. Developmental expression of monocyte chemoattractant protein-1 in the human cerebellum and brainstem. Brain Dev 1999, 21:30-35.
33. Zhou Y., Ling E.A., Dheen S.T. Dexamethasone suppresses monocyte chemoattractant protein-1 production via mitogen activated protein kinase phosphatase-1 dependent inhibition of Jun N-terminal kinase and p38 mitogen-activated protein kinase in activated rat microglia. J Neurochem 2007, 102:667-678.
34. Barrington K. The adverse neuro-developmental effects of postnatal steroids in the preterm infant: a systematic review of RCTs. BMC Pediatr 2001, 1:1.
35. Yeh T.F., Lin Y.J., Lin H.C., Huang C.C., Hsieh W.S., Lin C.H., et al. Outcomes at school age after postnatal dexamethasone therapy for lung disease of prematurity. N Engl J Med 2004, 350:1304-1313.
36. Shilling M., Strecker J.K., Schäbitz W.R., Ringelstein E.B., Kiefer R. Effects of monocyte chemoattractant protein 1 on blood-borne cell recruitment after transient focal cerebral ischemia in mice. Neuroscience 2009, 161:806-812.